Accuray Incorporated (NASDAQ ... and China. It offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary ...

For example, in December, the international Journal of Cancer, highlighted the CyberKnife System as an effective and time efficient treatment option for brain stem metastases. Additionally, in October ...

And also, within those markets, a breakthrough high-end premium technology like CyberKnife is also very attractive to establish the Accuray technology brand. So, it's not pricing, it is technology.

Accuray (NASDAQ:ARAY – Get Free Report ... and China. It offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment ...

Accuray Inc (ARAY) reports an 8% revenue increase, driven by robust product sales and significant growth in China and Japan.

And also, within those markets, a breakthrough high-end premium technology like CyberKnife is also very attractive to establish the Accuray technology brand. So, it’s not pricing, it is technology.